Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand

New Zealand Medical Journal

Volumn 113, Issue 1107, 2000, Pages 114-116

  Hopkirk, Nicola ^a   Moyes, Christopher D ^a   Lucas, C Ronald ^a  

^a Hepatitis Foundation   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; COHORT ANALYSIS; FEMALE; HEPATITIS B; HETEROZYGOTE; HUMAN; LIVER FUNCTION TEST; MALE; NEW ZEALAND; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HUMANS; LIVER FUNCTION TESTS; MALE; NEW ZEALAND;

EID: 0034646525     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Moyes CD, Milne A, Waldon J. Liver function of hepatitis B carriers in childhood. Pediatr Infect Dis J 1993; 12: 120-5.
2. Martin AR, Moyes CD, Lucas CR, Milne A. Hepatitis B infection in the households of HBsAg positive NZ children. NZ Med J. 1996; 1109: 463-5.
3. Robinson D, Whitehead TP. Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann Clin Biochem 1989; 26(Pt 5): 393-400.
4. Lok AS, Lai CL. Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. J Hepatol 1990; 100: 29-34.
5. Liaw YF, Chu CM, Su IJ et al. Clinical and histological events preceding HBeAg seroconversion in chronic type B hepatitis. Gastroenterology 1983; 84: 216-9.
6. Liaw YF, Tai Di, Chu CM, et al. The development of cirrhosis in patients with chronic type B hepatitis. Hepatology 1988; 84: 493-6.
7. Fattovich G, Brollo L, Alberti A et al. Long-term follow-up of anti-HBe-positive chronic active hepatitis B. Hepatology 1988; 8: 1651-4.
8. Lai ME, Solinas A, Mazzoleni AP, et al. The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study. J Hepatol 1994; 20: 773-81.
9. Chu CM, Yeh CT, Chiu CT et al. Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic. J Clin Microbiol 1996; 34: 1815-8.
10. Gane E. Chrome hepatitis B virus infection in south Auckland. NZ Med J 1998; 111: 120-3.
11. Bortolotti F. Chronic hepatitis B acquired in childhood- unanswered questions and evolving issues. J Hepatol 1994; 21: 904-9.
12. Ohnishi K, Iida S, Iwana S et al. The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma - relationship to HBsAg carriage. Cancer 1982; 49: 672-7.
13. Niederau C, Heintges T, Lange S, et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996; 334: 1422-7.
14. Hoofnagle JH, Di Bisceglie AM, Waggoner JG, Park Y, Kidney Diseases NloHBM. Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology 1993; 104: 1116-21.
15. Ikeda K, Saitoh S, Suzuki Y, et al. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study. Cancer 1998; 82: 827-35.